Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Foghorn Therapeutics (FHTX)

Annual Return

Over the past 3 years, FHTX has had an average annual return of -13.97%, underperforming the benchmark SPY, which returned +19.62% annual.

Over the past 5 years, FHTX has had an average annual return of -11.79%, underperforming the benchmark SPY, which returned +12.73% annual.

Since Oct 23, 2020, FHTX has had an average annual return of -19.64%, underperforming the benchmark SPY, which returned +15.96% annual.

2026202520242023202220212020
-4.43%+14.40%-26.83%+1.11%-72.10%+12.82%+11.87%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+5.74%-0.51%-15.85%-0.64%-9.88%+14.01%+5.76%-4.43%
2025-11.25%+15.79%-24.77%+15.09%-2.85%+15.19%+11.68%-3.62%-3.33%-9.82%+7.68%+13.70%+14.40%
2024-50.70%+143.08%-13.20%-18.63%+6.77%-1.37%+22.09%+17.97%+12.43%-18.16%+4.85%-40.92%-26.83%
2023+34.79%-33.38%+8.22%+5.14%-3.53%+11.93%+30.12%-17.35%-33.96%-32.98%+26.83%+51.81%+1.11%
2022-32.75%-37.51%+58.47%-23.90%+11.30%+5.44%+7.57%-32.05%-13.69%+1.86%-22.77%-5.48%-72.10%
2021-18.60%-0.24%-19.93%-16.69%-5.20%+2.51%-14.99%+43.09%+7.33%-8.91%-8.82%+97.67%+12.82%
2020-11.81%+26.41%+0.35%+11.87%

Drawdown analysis of Foghorn Therapeutics (FHTX)

The maximum drawdown for the FHTX was -89.11%, occurring on Feb 5, 2024. This drawdown has not yet recovered.

The current FHTX drawdown is -80.06%.

Since Oct 23, 2020 FHTX has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 4 times
DepthStartTo BottomBottomTo RecoverEndTotal
-89.11%Dec 18, 2020785Feb 5, 2024OngoingOngoingOngoing
-18.14%Nov 27, 20203Dec 2, 20203Dec 7, 20206
-16.56%Oct 23, 20203Oct 28, 202020Nov 25, 202023
-12.96%Dec 11, 20201Dec 14, 20203Dec 17, 20204
-8.67%Dec 8, 20202Dec 10, 20201Dec 11, 20203